eNOS mutations useful for gene therapy and therapeutic...

Details eNOS mutations useful for gene therapy and therapeutic... eNOS mutations useful for gene therapy and therapeutic...

2005-05-31

2005-05-31

Achutamurthy, Ponnathapu (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Oxidoreductase

C435S440000, C536S023200

Reexamination Certificate

active

06900038

ABSTRACT:
The present invention relates to new NOS variants or mutants which contain structural alterations in the site of Akt dependent phosphorylation. The altered NOS proteins or peptides, especially the human eNOS proteins or peptides, Akt proteins or polypeptides and their encoding nucleic acid molecules are useful as gene therapy agents for the treatment of diseases including post angioplasty restenosis, hypertension, atherosclerosis, heart failure, diabetes and diseases with defective angiogenesis. NOS proteins and peptides are also useful in methods of screening for agents which modulate NOS activity.

REFERENCES:
patent: 5498539 (1996-03-01), Harrison et al.
patent: WO 96/01902 (1996-01-01), None
patent: WO 00/20025 (2000-04-01), None
patent: WO 00/56866 (2000-09-01), None
patent: WO 00/77190 (2000-12-01), None
Alessi et al., 1996, Embo J 15:6541-6551.
Bredt et al., 1990, Proc. Natl. Acad Sci. U.S.A. 87:682-685.
Champion et al., 1999, Proc. Natl. Acad. Sci. 96:11648-11652.
Corson et al., 1996, Circulation Research 79:984-991.
Dimmeler et al., 1999, Nature 399:601-605.
Downward, 1998, Curr Opin Cell Biol 10:262-267.
Fulton et al., 1999, Nature 399:597-601.
Garcia-Cardena et al., 1998, Nature 392:821-824.
Garcia-Cardena et al., 1996, J Biol Chem 271:27237-27240.
Garcia-Cardeñia et al., 1996, Proc. Natl. Acad. Sci. USA 93:6448-6453.
Huang et al., 1995, Nature 377:239-242.
Kantor et al., 1996, Science 274:1744-1748.
Kelm et al., 1988, Biochem. Biophys. Res. Commun. 154:236-244.
Klatt et al., 1995, EMBO J. 14:3687-3695.
Liu et al., 1996, Biochemistry 35:13277-13281.
Liu et al., 1997, J. Cell Biol. 137,:1525-1535.
Martasek et al., 1999, Methods Enzymol 301:70-78.
Martasek et al., 1996, Biochem Biophys Res Commun 219:359-365.
Masters et al., 1967, Methods Enzymol. 10:565-573.
McCabe et al., 2000, J. Biol. Chem. 275:6123-6128.
Michel et al., 1993, Proc. Natl. Acad. Sci. 90:6252-6256.
Michell et al., 1999, Curr. Biol 9:845-848.
Murohara et al., 1998, J Clin Invest 101:2567-2578.
Papapetropoulos et al., 1997, J Clin Invest 100:3131-3139.
Rodriguez-Crespo, 1996, Arch. Biochem. Biophys. 336:151-156.
Roman et al., 1995, Proc. Natl. Acad. Sci. U.S.A. 92:8428-8432.
Rudic et al., 1998, J Clin Invest 101:731-736.
Sessa et al., 1995, J Biol Chem 270:17641-17644.
Shaul et al., 1996, J Biol Chem 271:6518-6522.
Shesely et al., 1996, Proc Natl Acad Sci USA 93:13176-13181.
Yano et al., 1998, Nature 396:584-587.
Yla-Herttuala et al., 2000, The Lancet:355:213-222.
Zhang et al., 1996, Biochem. Biophys. Res. Comm. 226:293-300
Chen et al., 1999, FEBS letters 443:285-289.
Coffer et al. 1991, Eur. J. Biochem. 201:475-482.
Fulton et al., 1998, FASEB J. 13:A47.
Gallis et al., 1999, J. Biol. Chem. 274:30101-30108.
Janssens et al. 1992, J. Bio. Chem. 267:14519-14522.
Matsui et al., 1999, Circulation, American Heart Association 100:2373-2379.

Affiliated with

Also associated with

Rating

eNOS mutations useful for gene therapy and therapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with eNOS mutations useful for gene therapy and therapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and eNOS mutations useful for gene therapy and therapeutic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3421976